Skip to content
Aussie8 – Lifestyle
Author:
Lakefront Biotherapeutics
Lakefront Announces Initiation of €50 Million Stock Repurchase Program
June 9, 2026
Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer
June 8, 2026
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
June 4, 2026
Lakefront Receives Transparency Notification from Bank of America
May 26, 2026